English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Pharmaceutical Research
Patient Daily
| Jan 26, 2026
PhRMA: PBMs and insurers raise patient costs while restricting access
Patient Daily
| Jan 16, 2026
PhRMA senior manager on PBMs: 'Drug spending is nearly 200% higher per patient at 340B hospitals'
Patient Daily
| Jan 7, 2026
PhRMA warns of cancer drug markups, 340B program profiteering
Patient Daily
| Dec 22, 2025
PhRMA Director on 340B: Hospitals are 'exploiting the program for profit'
Patient Daily
| Dec 1, 2025
PhRMA Senior Director on 340B abuse: 'If Congress is serious about lowering drug costs, they must reform 340B'
Trending
Patient Daily
| Mar 6, 2026
Dallas Breathe Free ranked top ENT practice in region by reviewers on Google
+
Pharmaceuticals
Patient Daily
| Mar 9, 2026
Rep. Marshall on 340B expansion: 'If 340B is to continue growing, lawmakers should ensure it truly benefits the underserved'
+
Pharmaceuticals
Patient Daily
| Mar 7, 2026
Merck and Pfizer report positive phase 3 results for bladder cancer drug combination
+
Pharmaceuticals
Patient Daily
| Mar 7, 2026
FDA prepares decisions on key drugs from BMS, GSK, Aldeyra and others
